The FDA has expanded the labeling for Izervay (avacincaptad pegol) to include longer-term administration for geographic ...

Eli Lilly has announced results from the VIVID-2 open-label extension study, showing that most patients with moderately to ...

Revenue in Q4 2024 increased 45% to $13.53 billion driven by volume growth from Mounjaro and Zepbound. Non-incretin revenue(i) grew by 20% compared to Q4 2023. Pipeline ...

Revenue in Q4 2024 increased 45% to $13.53 billion driven by volume growth from Mounjaro and Zepbound. Non-incretin revenue(i) grew by 20% compared to Q4 2023.Pipeline progress included the approval ...

Then, in January, the FDA approved the company's drug Omvoh for Crohn's disease. The drug was first approved in October 2023 for patients with moderately to severely active ulcerative colitis ...

The Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn disease in adults.

EXTON, PA, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The FDA's approval of Eli Lilly’s Omvoh for Crohn’s disease marks a significant milestone as the therapy becomes the second IL-23 inhibitor ...

REUTERS — The U.S. Food and Drug Administration has proposed requiring packaged foods to carry a front-of-package nutrition label. The proposal plays a key role in the agency’s nutrition ...

A shopper looking to use wrapping paper for their holiday gifting ended up unwrapping a surprise of their own. On a recent post on Reddit's r/mildlyinfuriating, a shopper found that all ten sheets of ...

The updated definition will reflect those changes. The FDA is also testing new front-of-package labels to help consumers quickly identify whether a product meets the new health standards.